Neogen Beats Expectations, Shares Soar
Update: 2026-01-08
Description
Neogens Q4 CY2025 results exceeded Wall Street expectations, with revenue of $224.7M (up 50% YoY) and EPS of $0.10 (50% above estimates). The company raised full-year revenue guidance to $850M (3% above estimates) and EBITDA guidance to $175M (10% above estimates). Despite improved operating margins, long-term trends show challenges, including revenue decline and negative margins. However, the quarters strong performance boosted shares by 19.8% to $8.84. Checkout Solipillow.com
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
